UCOE Fragments Stabilize Transgene Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating high and reproducible levels of gene expression in mammalian cells are hindered by position effect variegation and rapid silencing of transgenes, particularly due to the random integration of chromatin domains, which limits the efficiency and stability of transgene expression in both research and biotechnological applications.
Innovation Solution
The development of smaller polynucleotides comprising functional fragments of Ubiquitous Chromatin Opening Elements (UCOEs), specifically methylation-free CpG islands of no more than 2 kb, which are operably linked to expressible open reading frames and promoters, to establish and maintain an open chromatin structure, thereby enhancing gene expression levels and consistency across different tissues.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If random integration of transgenes is used, then gene expression can be achieved, but position effect variegation and rapid silencing occur leading to low expression stability
Solution Approach 1:
The patent introduces Locus Control Regions (LCRs) as intermediary elements that mediate between the transgene and the chromatin environment. These LCRs act as buffer zones that prevent harmful chromatin interactions from affecting transgene expression, thereby stabilizing expression levels across different genomic integration sites.
Solution Approach 2:
The patent employs chromatin-opening elements and histone acetylation mechanisms that preemptively establish an open chromatin configuration at the transgene integration site before transcription begins. This preliminary chromatin remodeling prevents subsequent silencing events and ensures consistent expression.
2Reliability
If tissue-specific LCRs are used to establish open chromatin structure, then high gene expression levels are achieved, but tissue-specificity limits universal application
Solution Approach 1:
The patent designs LCR constructs with universal promiscuous promoter elements that can function across multiple tissue types and cell lines. These universal LCRs maintain the ability to establish open chromatin structures and drive high-level expression without being restricted to specific tissues, thereby achieving both high expression and broad applicability.
3Reliability
If large UCOE fragments are used to maintain open chromatin structure, then expression stability is improved, but vector size increases reducing cloning capacity
Solution Approach 1:
The patent segments the LCR and UCOE elements into modular functional units that can be independently optimized and assembled. This segmentation allows selection of minimal functional fragments that retain chromatin-opening activity while reducing overall vector size. The modular design also enables flexible assembly tailored to specific application needs.
Solution Approach 2:
The patent systematically varies the size, sequence composition, and structural parameters of UCOE fragments to identify minimal functional units. By changing these parameters, the patent identifies compact UCOE elements that maintain chromatin-opening capability while minimizing vector size, achieving optimal balance between expression stability and cloning capacity.
Data Source
AI summary
The invention relates to improved genetic elements providing high levels of expression of operably-linked genes in a variety of tissues. In particular, fragments of unmethylated, CpG islands of less than 2 kb are shown to provide enhanced transgene expression and have advantages in terms of vector construction and cloning capacity.